Love Research Army
The Love Research Army, formerly known as the Army of Women, is committed to encouraging and facilitating breast cancer research in all people, regardless of age, race, gender, sexual identity, with or without a breast cancer diagnosis. We combat the disparities that exist in research by challenging the scientific community to launch studies that are as inclusive and diverse as the people that breast cancer affects. We consistently and intentionally recruit members who are willing and excited to participate in breast cancer research. We are committed to thoughtfully engaging over 78,000 supporters by providing them with ongoing, real-time access to an array of studies.
To stay up to date on the latest research studies seeking participants, please join our Love Research Army mailing list!
Open Love Research Army Studies
The following projects are currently open and enrolling volunteers. These studies have been evaluated and approved by the research team at Dr. Susan Love Foundation and members of our external Scientific Advisory Committee, comprised of researchers, clinicians, and advocates.
Looking for a specific type of study? Finding the right fit is simple:
Select your criteria below, and press submit to view your results.
An Exploration of the Perceptions of Cancer Educational Materials for Young Women with Breast Cancer and Implications for Material Development
Researcher Parker Pearman, CON College of Nursing Research Summary Cancer educational materials disseminate complex conceptual health information in print-heavy formats and can be difficult to understand especially when the most recent National Assessment of...
Agreement to Participate in the Effect of the COVID-19 Pandemic on the Wellness Activities and Well-Being of Cancer Survivors: Insights for Interventions Moving Forward
Researcher Jessica Clague DeHart, PhD, MPH, Assistant Professor Summary This survey study examines the impacts of the COVID-19 pandemic on the wellness activities of cancer survivors. In addition to investigating how habits might have changed, this study will...
BREAST Q-Patient Reported Outcome Measure for Measuring Health Related Quality of Life in Breast Cancer
Researcher Sophocles Voineskos MD, McMaster University Summary The BREAST-Q is currently the gold standard patient-reported outcome measure (PROM) for measuring health-related quality of life in breast cancer. Recently, new BREAST-Q scales have been developed and...
RECONJOINT – Survey to Assess Patient Preferences for Breast Reconstruction
Researcher Ronnie Shammas, MD, Plastic Surgery Resident, Duke University Medical Center, Durham, North Carolina Summary Approximately 40% of breast reconstruction patients experience dissatisfaction due to inaccurate expectations of post-surgical well-being, and...
Symptom Burden and Cognitive Function in Older Breast Cancer Survivors
Researcher Jungeun Lee, PhD, MSN, RN, University of Rhode Island College of Nursing Summary Research has shown that of the long-term symptoms of cancer treatment that survivors experience, cancer-related fatigue is one of the most burdensome, along with sleep...
A Study of Activation from Tumor Dormancy in ER-positive Breast Cancer Patients
Researcher Steven Narod, MD, and Carol Townsley, MD; Women’s College Research Institute, Toronto, ON, Canada. Summary Doctors do not know which women treated for early-stage estrogen receptor-positive (ER+) breast cancer will have their cancer come back in their...
Breast Cancer Treatment in Women with PALB2 Mutations
Researcher Kelly Metcalfe, PhD, Women’s College Research Institute, Toronto, ON, Canada Summary Research has shown that people who have inherited a mutation in the PALB2 gene are at increased risk for breast cancer. We have learned a lot about breast cancer that...
Randomized Clinical Trial of RANKL Inhibition with Denosumab on Mammographic Density in High Risk Premenopausal Women with Dense Breasts
Researcher Adetunji T. Toriola, MD, PhD, MPH, Washington University School of Medicine, St. Louis, MO Summary Studies have shown that women with dense breasts are at increased risk for breast cancer. The drug tamoxifen has been shown to reduce breast cancer risk in...
Communication & Companions in Cancer Care
Researcher Kathryn Greene, PhD, Rutgers University; Katie Devine, PhD, Rutgers Cancer Institute of New Jersey; Smita Banerjee, PhD, Memorial Sloan Kettering Cancer Center; Maria Venetis, PhD, Rutgers University; Danielle Catona, PhD, George Mason University; Maria...
Predicting Brain Health After Chemotherapy
Researcher Shelli Kesler, PhD, University of Texas at Austin, Austin, TX Summary We need women with a history of breast cancer who have completed chemotherapy treatment at least 1 month ago and healthy women to help researchers gain a better understanding of the...
Study to Understand Changes in Thinking in Breast Cancer Patients
Researcher Tim Ahles, PhD, and James Root, PhD, at Memorial Sloan Kettering Cancer Center Summary Breast cancer treatments may have an impact on how the brain processes information and emotions as well as on a person’s attention span and behavior. To better understand...
Genomic Analysis of Long-Term Survivors with Metastatic Cancer
Researcher Mark Burkard, MD, PhD, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin Summary Some people live for many years following a metastatic breast cancer diagnosis. To gain insight into why researchers want to learn more about the medical...
WISDOM Study
Researcher Laura Esserman, MD, MBA, University of California, San Francisco, CA and her partners from the Athena Breast Health Network (a collaboration across the five University of California Medical Centers and Sanford Health) Summary Women receive mixed messages...
Risk Factor Analysis of Hereditary Breast and Ovarian Cancer
Researcher Steven Narod, MD, Women's College Research Institute, Toronto, Ontario, Canada Summary Genetic and non-genetic factors are believed to influence whether a woman with a BRCA1, BRCA2, and/or PALB2 mutation goes on to develop breast and/or ovarian cancer. The...
Watch Past Study Webinars
Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors
This webinar featured Maurade Gormley, MSN, from New York University, who discussed the quantitative findings from her study titled, "Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors," which was supported by the Love...
Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors
This webinar featured Maurade Gormley, MSN, from New York University, who discussed the quantitative findings from her study titled, "Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors," which was supported by the Love...
Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors
This webinar featured Maurade Gormley, MSN, from New York University, who discussed the quantitative findings from her study titled, "Exploring the Effects of Genomic Testing on Fear of Cancer Recurrence among Breast Cancer Survivors," which was supported by the Love...
The Financial Impact of Pursuing Breast Reconstruction
This webinar featured Dr. Nishant Ganesh Kumar from the University of Michigan who discussed the findings from his study titled, "The Financial Impact of Pursuing Breast Reconstruction" which was supported by the Love Research Army.
The Financial Impact of Pursuing Breast Reconstruction
This webinar featured Dr. Nishant Ganesh Kumar from the University of Michigan who discussed the findings from his study titled, "The Financial Impact of Pursuing Breast Reconstruction" which was supported by the Love Research Army.
The Financial Impact of Pursuing Breast Reconstruction
This webinar featured Dr. Nishant Ganesh Kumar from the University of Michigan who discussed the findings from his study titled, "The Financial Impact of Pursuing Breast Reconstruction" which was supported by the Love Research Army.
Male Breast Cancer Collateral Damage Survey
This webinar featured Dr. Deanna Attai from the David Geffen School of Medicine at UCLA who discussed the findings from her pilot study titled, "The Male Breast Cancer Collateral Damage Survey," which was supported by the Love Research Army.
Male Breast Cancer Collateral Damage Survey
This webinar featured Dr. Deanna Attai from the David Geffen School of Medicine at UCLA who discussed the findings from her pilot study titled, "The Male Breast Cancer Collateral Damage Survey," which was supported by the Love Research Army.
Male Breast Cancer Collateral Damage Survey
This webinar featured Dr. Deanna Attai from the David Geffen School of Medicine at UCLA who discussed the findings from her pilot study titled, "The Male Breast Cancer Collateral Damage Survey," which was supported by the Love Research Army.